Resmed (RMD) Short term Debt (2010 - 2026)

Resmed has reported Short term Debt for 17 years, with the latest figure at $259.9 million in Q1 2026.

• For the quarter ending Q1 2026, Short term Debt rose 2523.95% year-over-year to $259.9 million; the trailing twelve-month figure through Mar 2026 stood at $259.9 million (up 2523.95% YoY), and the FY2025 full-year result was $9.9 million, changed 0.0% from the prior year.
• Short term Debt for Q1 2026 stood at $259.9 million, roughly flat from $259.9 million in the prior quarter.
• The five-year high for Short term Debt was $259.9 million in Q1 2026, with the low at $9.9 million in Q3 2024.
• Historically, Short term Debt has averaged $54.1 million across 5 years, with a median of $9.9 million in 2023.
• Annual changes were most pronounced in 2022 — Short term Debt slipped 17.5% — and 2025, when it jumped 2526.3%.
• Resmed's Short term Debt stood at $9.9 million in 2022, then retreated by 0.02% to $9.9 million in 2023, then climbed by 0.08% to $9.9 million in 2024, then jumped by 2523.72% to $259.9 million in 2025, then climbed by 0.01% to $259.9 million in 2026.
• The last three Short term Debt figures came in at $259.9 million (Q1 2026), $259.9 million (Q4 2025), and $259.9 million (Q3 2025), per Business Quant data.